Nykode Therapeutics AS (VACBF) Q4 2023 Earnings

28FebConfirmed
Q4 2023
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.051615
Actual EPS
-0.016016
Surprise EPS
0.04
Surprise Percent
+68.97%

Description

Nykode Therapeutics AS (VACBF) has reported earnings of -0.016016 per share for Q4 2023.

0 Comments

Share your thoughts